IN PRICE GOUGING, AND SHAREHOLDERS ARE CONCERNED ABOUT
THAT BECAUSE IF A PHARMACEUTICAL COMPANY GOES TOO FAR,
SHAREHOLDERS INVESTED IN THAT COMPANY COULD BE AT RISK.
AS A
RESULT, SHAREHOLDERS WERE
PUSHING FOR REGULATION THAT WOULD FORCE PHARMACEUTICALS TO
DISCLOSE WHAT THEIR RATIONALE IS FOR INCREASING PRICES FOR
VARIOUS MEDICATION.
YOU WOULD THINK TRUMP, WHO CLAIMED HE WAS
GOING TO BE TOUGH ON PHARMACEUTICALS WOULD SIDE WITH
SHAREHOLDERS.
IT TURNS OUT SOME OF THE PEOPLE HE APPOINTED ARE
VERY MUCH AGAINST THE BEST AND
HAD PUT A STOP
TO IT.
>> MY TAKE ON THIS IS A TINY BIT COMPLICATED.
FIRST OFF, IF THIS
WAS APPLIED TO ANY RANDOM
INDUSTRY I THINK I WOULD VOTE NO.
IF THEY SAID TO NIKE YOU
HAVE TO TELL US HOW YOU JUSTIFY THE PRICE OF YOUR SNEAKERS I
WOULD SAY THAT IS KIND OF THEIR BUSINESS, NOT YOUR BUSINESS.
PEOPLE EITHER BY SNEAKERS OR
THEY DON'T BUY THE SNEAKERS.
I WOULD VOTE NO ON THAT IF I WAS A
SHAREHOLDER THAT CAME UP IN THE NIKE'S SHAREHOLDER MEETING.
I
WOULD CONSIDER THAT
OVERREGULATION.
ONE, HEALTHCARE IS NOT NIKE'S.
HEALTHCARE
APPLIES ALL OF US AND YOU'VE GOT ALL THESE MIDDLEMEN, INSURANCE
COMPANIES THAT ARE MAKING A PROFIT OFF OF US.
WE CAN
ACTUALLY GET HEALTHCARE INSURANCE DIRECT FROM THE
GOVERNMENT AS ALMOST ALL OF THE DEVELOPED COUNTRIES DO THEN WE
WOULD CUT OUT THEIR PROFITS WHICH IS SOMETIMES 15 TO 20%, IF
NOT MUCH HIGHER.
SO WHEN WE SAY IT MIGHT BE GOOD TO SEE HOW THE
HEALTHCARE COMPANIES JUSTIFY THEIR COST, THAT MAKES MORE
SENSE TO THE PUBLIC.
IN THIS CASE IT IS NOT US ASKING, IT'S
THE SHAREHOLDERS OF THOSE
COMPANIES ASKING.
ON THAT NOTE I NEVER UNDERSTAND WHY THIS IS
EVEN A QUESTION.
THE
SHAREHOLDERS OF THE COMPANY ARE THE OWNERS OF THE COMPANY.
EVERY
ONCE IN A WHILE CORPORATE EXECUTIVES SAY I DON'T CARE WHAT
MY OWNERS WANT.
WHAT THE HELL?
THAT IS HOW CAPITALISM WORKS
RIGHT?
SO I AM GOING TO TELL POLITICIANS, IN THIS CASE THE
REPUBLICAN PARTY DON'T LET THE OWNERS OF THE COMPANY VOTE ON
WHETHER THEY CAN SEE THIS
INFORMATION.
IT IS ONE THING IF THEY VOTE, AND THEY MIGHT VOTE
NO LIKE I WOULD.
BUT IT IS ANOTHER THING IF YOU SAY THEY
ARE NOT ALLOWED TO VOTE.
HOW COULD THE SHAREHOLDERS NOT BE
ALLOWED TO VOTE ON A COMPANY
THEY OWN?
THIS ISN'T CAPITALISM, IT IS CRONY CAPITALISM.
>>THIS IS THE FIRST STEP AND FORESHADOWING OF WHAT
PHARMACEUTICAL COMPANIES WILL BE LIKE UNDER TRUMP'S
ADMINISTRATION.
IMMEDIATELY AFTER TRUMP MET WITH THESE
PHARMACEUTICALS THINGS CHANGE VERY QUICKLY.
YOU DON'T HEAR A
LOT FROM HIM, ESPECIALLY IN THE MIDST OF ALL THESE HEALTHCARE
DEBATES.
YOU DON'T HEAR ANYTHING FROM HIM REGARDING THE PRICE OF
MEDICINE AND WHY IT IS IN CANADA YOU CAN BUY MUCH CHEAPER
PHARMACEUTICAL DRUGS.
LET ME GIVE YOU SOME MORE INFORMATION.
BY THE WAY LET'S EMPHASIZE IT WASN'T JUST REPUBLICANS, IT WAS
DEMOCRATS AS WELL.
SOME OF THESE SHAREHOLDERS ARE UPSET ABOUT
THIS.
OF COURSE THEY ARE CONCERNED ABOUT THE AMERICAN
PUBLIC, BUT MOST OF IT COMES DOWN TO THEM AND THEIR BUSINESS.
LET ME GIVE YOU A STATEMENT FROM
SUSAN VICKERS.
>>LET'S DO ONE EXAMPLE.
I'M NOT SAYING THEY DO THIS, BUT THEY
COULD.
WHAT IF THEY SAID WE ARE GOING TO INCREASE PRICES BY 25%.
WHY?
WE ARE NOT GOING TO TELL YOU.
IF IT LOOKS OUT THEY
INCREASED IT BECAUSE THEY WANT
TO GET 24% OF THAT TO GIVE TO THEIR EXECUTIVES.
AS A
SHAREHOLDER IN THE COMPANY I
WOULD LIKE TO KNOW THAT.
THAT IS MORE COMPLICATED BECAUSE THERE
ARE MANY RULES GOVERNING CONVERSATIONS FOR EXECUTIVES AND
ETC.
YOU CAN SEE WHY THEY MIGHT WANT TO KNOW WHAT YOU ARE DOING
WITH THEIR COMPANY.
IT IS INCREDIBLE ARROGANCE ON THE PART
OF THEIR EXECUTIVES TO SAY THEY WILL NOT BE TELLING THE OWNERS
ANYTHING.
AGAIN, REPUBLICANS SAYING ONE THING AND DOING
ANOTHER.
I DON'T LIKE PARTISANSHIP, SO WHEN OBAMA AND
BUSH BOTH GAVE DRUG COMPANIES THIS MONOPOLY WHERE WE COULD NOT
NEGOTIATE DRUG PRICES IT DIDN'T
MAKE IT ANY BETTER.
WHEN TRUMP SAID HE WAS GOING TO TAKE THAT
AWAY I SAID GREAT AND GAVE HIM CREDIT FOR THAT.
WHEN YOU ARE
NOT LOOKING WHAT DOES HE DO?
>> NOTHING IS GOING TO GET BETTER UNDER TRUMP.
ANYTHING HE
CLAIMED TO DO THAT WOULD APPEAL
TO LIBERALS HE IS NOT GOING TO DO AND HE HAS BEEN CLEAR ABOUT
THAT.